Senior insider sale
EVP & Co-Head Research & Inv. at ROYALTY PHARMA PLC — senior position signals high conviction
$1.46M
36.48K shares
What this filing means
URIST MARSHALL plans to sell 36.48K shares of ROYALTY PHARMA PLC valued at approximately $1.46M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/1/2025ACC: 0001964306-25-000422
Officer· EVP & Co-Head Research & Inv.
Since Dec 2020
36.48K
Shares to sell
$1.46M
Approx. market value
36.48K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Equity Performance Award
Granted as part of issuer equity compensation program
5/8/2025
36.48KTotal acquired36.48K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/8/2025 | Equity Performance Award Granted as part of issuer equity compensation program | 36.48K | — |
| Total | 36.48K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
36.48K
Market value
$1.46M
12/1/2025
Total
Units
36.48K
Value
$1.46M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/1/2025 | 36.48K | $1.46M | NASDAQ | Planned |
| Total | 36.48K | $1.46M | ||